PMID- 24420924 OWN - NLM STAT- MEDLINE DCOM- 20140923 LR - 20211021 IS - 1573-7373 (Electronic) IS - 0167-594X (Linking) VI - 116 IP - 3 DP - 2014 Feb TI - CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation. PG - 625-32 LID - 10.1007/s11060-013-1349-2 [doi] AB - Cullin 4A (CUL4A) encodes a core subunit of an E3 ubiquitin ligase that targets proteins for ubiquitin-mediated degradation, and aberrant expression of the CUL4A is found in many tumor types. However, its roles and clinicopathologic significance in pituitary adenomas are not clear. The aim of this study was to investigate the possible role of CUL4A in pituitary tumorigenesis. Immunohistochemistry was used to examine CUL4A expression in human normal pituitaries and pituitary tumors with respect to various clinicopathologic factors in pituitary adenomas. Cell proliferation was assessed by MTT and colony formation, and migration and invasion were analyzed by Transwell and Matrigel assays after CUL4A overexpression or knockdown in pituitary tumor cells. Overexpression of CUL4A was frequently observed in pituitary adenomas compared with normal adenohypophysial tissue and significantly associated with tumor progressiveness and invasion. CUL4A overexpression in GH3 adenoma cells increased colony numbers, cell viability and cell invasion and silencing CUL4A in AtT20 adenoma cells decreased cell proliferation, migration and invasion. Mechanistically, CUL4A could modulate the expression of p53, p21, and p27 in pituitary tumor cells. In addition, high levels of CUL4A expression also significantly inversely correlated with the p53 protein level in human pituitary adenomas. Our results indicate that CUL4A enhances pituitary cell proliferation, migration and invasion and may thus contribute to pituitary tumor development and progression. FAU - Xu, Yangyang AU - Xu Y AD - Department of Anatomy and Key Laboratory of Experimental Teratology, Ministry of Education, Shandong University School of Medicine, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China. FAU - Wang, Yunshan AU - Wang Y FAU - Ma, Guangxin AU - Ma G FAU - Wang, Qin AU - Wang Q FAU - Wei, Guangwei AU - Wei G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140114 PL - United States TA - J Neurooncol JT - Journal of neuro-oncology JID - 8309335 RN - 0 (CUL4A protein, human) RN - 0 (Cullin Proteins) RN - 0 (RNA, Small Interfering) RN - 0 (Tumor Suppressor Protein p53) RN - 9002-60-2 (Adrenocorticotropic Hormone) RN - 9002-62-4 (Prolactin) RN - 9002-72-6 (Growth Hormone) SB - IM MH - Adenoma/*metabolism/pathology MH - Adrenocorticotropic Hormone/metabolism MH - Animals MH - Cell Line, Tumor MH - Cell Proliferation MH - Cullin Proteins/genetics/*metabolism MH - Female MH - Gene Expression Regulation, Neoplastic/*genetics MH - Growth Hormone/metabolism MH - HEK293 Cells MH - Humans MH - Male MH - Mice MH - Pituitary Neoplasms/*metabolism/pathology MH - Prolactin/metabolism MH - RNA, Small Interfering/genetics/metabolism MH - Retrospective Studies MH - Time Factors MH - Tumor Cells, Cultured MH - Tumor Suppressor Protein p53/metabolism EDAT- 2014/01/15 06:00 MHDA- 2014/09/24 06:00 CRDT- 2014/01/15 06:00 PHST- 2013/06/22 00:00 [received] PHST- 2013/12/29 00:00 [accepted] PHST- 2014/01/15 06:00 [entrez] PHST- 2014/01/15 06:00 [pubmed] PHST- 2014/09/24 06:00 [medline] AID - 10.1007/s11060-013-1349-2 [doi] PST - ppublish SO - J Neurooncol. 2014 Feb;116(3):625-32. doi: 10.1007/s11060-013-1349-2. Epub 2014 Jan 14.